From over 100,000 films, discover the handful you'll love.
Free or premium access to the world's largest documentary library.
19 films
Insys Therapeutics profited from a fentanyl-based painkiller by bribing doctors and misleading insurers, ultimately leading to federal prosecution and prison sentences for executives.
One in five Americans takes a psychiatric drug, with pharmaceutical companies promoting benefits while downplaying risks and side effects.
The global pharmaceutical industry prioritizes profits over people, revealing the lengths companies will go to secure drug approvals and maximize prices.
Mefloquine, an anti-malarial drug developed by the US Army, has raised concerns over its psychiatric side effects and the lack of transparency surrounding its use.
Five and a half years is the prison sentence given to John Kapoor for his role in promoting a fentanyl spray that contributed to the opioid crisis.
Prescription anti-depressant medications are examined for their effectiveness in addressing the rising rates of anxiety and depression in the United States.
Pharmaceutical companies prioritize lifestyle drugs for Western markets over essential treatments for diseases like AIDS and tuberculosis in Africa.
Dr. Chris Van Tulleken examines the dramatic rise in ADHD prescriptions and the impact of over-the-counter medications on children's health and behavior.
Sleeping sickness in Sudan highlights the failure of the global pharmaceutical market to provide affordable treatments for impoverished populations.
Fukushima's ongoing crisis raises concerns about Japan's nuclear safety, while veterans grapple with mental health issues exacerbated by over-prescription.
Quaaludes, once popular in the U.S., are now confined to South Africa, where their history intertwines with dark medical experimentation.
AstraZeneca appoints Pascol Soriot from Roche as its new chief executive amid struggles.
Autism rates in the United States have increased by 600% over the last 20 years, prompting some parents to seek cannabis as a treatment option.
The UK approves CRISPR therapy for sickle cell disease, marking a medical breakthrough.
GSK admits that some employees broke laws amid a widening corruption probe in China.
Novartis and GSK restructure with significant transactions to enhance market positions.
The UK drugs industry sues the NHS over strict medicine price limits imposed on taxpayers.
Traditional large healthcare companies face challenges from emerging HealthTech innovations.
Oliver Lex critiques Reckitt Benckiser's split of its Pharmaceuticals business and its value potential.
